Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aeroscena
AddedFeb 18, 2024
UpdatedJun 18, 2026
Aeroscena

Aeroscena

Angel

Provider of clinical aromatherapy solutions.

HQ
Cleveland, OH, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

Aeroscena, founded with a mission to integrate clinical aromatherapy into healthcare, focuses on providing evidence-based essential oil solutions designed to improve patient outcomes. Their vision is to make aromatherapy a standard complementary treatment in medical settings. Aeroscena offers proprietary essential oil formulas targeting specific needs such as calm, sleep, focus, and nausea relief. Their delivery systems include inhalers, patches, gel room diffusers, solid essential oil gels, and bottled oils. The company primarily serves clinical applications in cancer care, palliative care, dialysis, dentistry, and maternal health, as well as commercial sectors like hospitality.

Notable figures associated with Aeroscena include CEO Mark Kohoot. The company has achieved significant milestones by developing a range of innovative aromatherapy products that are used in various clinical settings. Their impact is evident in the improved well-being of patients and the growing acceptance of aromatherapy in mainstream healthcare. Aeroscena's contributions have positioned them as a leader in clinical aromatherapy solutions, fostering a holistic approach to patient care.

Aeroscena - Quick Facts

When was Aeroscena founded?

Aeroscena was founded in 2010.

Where is Aeroscena's headquarters located?

Aeroscena's headquarters is located in Cleveland, OH, US.

When was Aeroscena's last funding round?

Aeroscena's most recent funding round was for $400k (USD) in November 2011.

How much has Aeroscena raised to-date?

As of Nov 21, 2011, Aeroscena has raised a total of $400k (USD).

How many employees does Aeroscena have?

Aeroscena has 30 employees as of Feb 4, 2024.

Aeroscena - Classification

Ownership
  • Private
Technology
  • Aromatherapy
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Aromatherapy
Tags
  • eCommerce
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 4 more industry codes
NAICS
  • 621000Ambulatory Health Care Services
  • 621300Offices of Other Health Practitioners
  • 621320Offices of Optometrists
SIC
  • 8042Offices And Clinics Of Optometrists